國立高雄大學圖資館 |

Language: English

Back

Colitis-associated cancer

Kusunoki, Masato.

Colitis-associated cancer

Record Type:	Electronic resources : Monograph/item
Title/Author:	Colitis-associated canceredited by Masato Kusunoki.
other author:	Kusunoki, Masato.
Published:	Tokyo :Springer Japan :2016.
Description:	viii, 150 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Inflammatory bowel diseases.
Online resource:	http://dx.doi.org/10.1007/978-4-431-55522-3
ISBN:	9784431555223$q(electronic bk.)

Colitis-associated cancer
Colitis-associated cancer[electronic resource] /edited by Masato Kusunoki. - Tokyo :Springer Japan :2016. - viii, 150 p. :ill., digital ;24 cm.

Chapter 1 Colitis-Associated Cancer: Overview -- Part I Clinical Features -- Chapter 2 Incidence and Risk Factors -- Chapter 3 Prevention and Prognosis -- Part II. Diagnosis -- Chapter 4 Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- Chapter 5 Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- Chapter 6 Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- Chapter 7 Surgical Treatment for Colorectal Cancer in Crohn's Disease.

As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn's disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.

ISBN: 9784431555223$q(electronic bk.)

Standard No.: 10.1007/978-4-431-55522-3doiSubjects--Topical Terms:

274895
Inflammatory bowel diseases.

LC Class. No.: RC280.C6

Dewey Class. No.: 616.994347

Colitis-associated cancer
LDR:02500nmm a2200313 a 4500 001 481901
003 DE-He213
005 20160727151304.0
006 m d
007 cr nn 008maaau
008 161007s2016 ja s 0 eng d
020 $a 9784431555223$q(electronic bk.)
020 $a 9784431555216$q(paper)
024 7 $a 10.1007/978-4-431-55522-3 $2 doi
035 $a 978-4-431-55522-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.C6
072 7 $a MN $2 bicssc
072 7 $a MED085000 $2 bisacsh
082 0 4 $a 616.994347 $2 23
090 $a RC280.C6 $b C696 2016
245 0 0 $a Colitis-associated cancer $h [electronic resource] / $c edited by Masato Kusunoki.
260 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2016.
300 $a viii, 150 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1 Colitis-Associated Cancer: Overview -- Part I Clinical Features -- Chapter 2 Incidence and Risk Factors -- Chapter 3 Prevention and Prognosis -- Part II. Diagnosis -- Chapter 4 Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- Chapter 5 Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- Chapter 6 Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- Chapter 7 Surgical Treatment for Colorectal Cancer in Crohn's Disease.
520 $a As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn's disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.
650 0 $a Inflammatory bowel diseases. $3 274895
650 0 $a Ulcerative colitis. $3 738247
650 0 $a Crohn's disease. $3 456322
650 0 $a Rectum $x Cancer. $3 340159
650 0 $a Colon (Anatomy) $x Cancer. $3 340158
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Surgery. $3 274153
650 2 4 $a Surgical Oncology. $3 274092
650 2 4 $a Cancer Research. $3 273660
650 2 4 $a Gene Function. $3 456568
700 1 $a Kusunoki, Masato. $3 738246
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-4-431-55522-3
950 $a Medicine (Springer-11650)